| Pharmaceutical active ingredients: |
| Carboplatin |
| Available forms, composition and doses of Paraplatine: |
| Injectable; Injection; Carboplatin 10 mg / ml |
| Paraplatine medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XA02 - Carboplatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers Squibb |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Parapan | Acetaminophen | Unidentified Pharmaceutical Company |
| Parapic | Benzalkonium Chloride; Diphenhydramine Hydrochloride; Lidocaine Hydrochloride; Menthol; Vitamin B5 (Dexpanthenol) | Biomed |
| Para-Pio | Piperonyl Butoxide; Pyrethrin | Gestafarma Sociedade Farmaceutica |
| Paraplatin | Carboplatin | Bristol-Myers Squibb; DKSH; Four Star |
| Paraplatin-AQ | Carboplatin | Bristol-Myers Squibb |
| Parapleuro Shield P | Actinobacillus Parapleuropneumoniae; Haemophilus Parasuis; Pasteurella Multocida | Novartis |
| Para-Plus | Malathion; Permethrin; Piperonyl Butoxide | Omega Pharma; FIC Medical; Medgenix Benelux; Olvos Science; Pacific Pharmaceuticals; Pharmygiene-SCAT Laboratoires; Rafa Laboratories; Raymos Laboratorios |
| Parapoux | Permethrin | Omega Pharma |
| Parapres | Candesartan Cilexetil | Almirall |
| Parapres Plus | Candesartan Cilexetil; Hydrochlorothiazide | Almirall |